Company: PTHS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001753926-25-001764
Chunk: 191

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 2
Chunk 191
---
uant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    101
     
    Interactive Data Files (embedded within the Inline XBRL document)

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

+ Indicates
management contract or compensatory plan.

In accordance with SEC Release 33-8238, Exhibit 32.1 and 32.2
are being furnished and not filed.

72

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Date: November 13, 2025

    Pelthos Therapeutics Inc.

    By:
    /s/ Scott Plesha

    Name: Scott Plesha

    Title: Chief Executive Officer and President (Principal Executive Officer)

    By:
    /s/ Francis Knuettel II

    Name: Francis Knuettel II

        Title: Chief Financial Officer, Treasurer
and Secretary
        (Principal Financial Officer, Principal Accounting
Officer)

73